{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T04:16:54Z","timestamp":1742444214921,"version":"3.40.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,19]]},"DOI":"10.7759\/cureus.80829","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T15:18:13Z","timestamp":1742397493000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case Report of a 61-Year-Old Woman With Jaundice and Cholelithiasis Presenting With Autoimmune Hepatitis"],"prefix":"10.7759","author":[{"given":"Nicholas P","family":"Michalakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archit","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Awais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Harrison's principles of internal medicine","author":"Kasper D","year":"2015","unstructured":"Kasper D, Fauci A, Hauser S, Longo D, Jameson J. Harrison's principles of internal medicine. McGraw-Hill Education, New York (NY); 2015."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"Prati D","year":"2002","unstructured":"Prati D, Taioli E, Zanella A, et al.. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002, 137:1-10. 10.7326\/0003-4819-137-1-200207020-00006","journal-title":"Ann Intern Med"},{"key":"ref3","article-title":"Liver function tests","author":"Lala V","year":"2023","unstructured":"Lala V, Zubair M, Minter DA. Liver function tests. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref4","article-title":"Cholestatic jaundice","author":"Shah R","year":"2025","unstructured":"Shah R, Grant LM, John S. Cholestatic jaundice. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.05.008","article-title":"Diagnosis and management of cholestatic liver disease","volume":"5","author":"Heathcote EJ","year":"2007","unstructured":"Heathcote EJ. Diagnosis and management of cholestatic liver disease. Clin Gastroenterol Hepatol. 2007, 5:776-82. 10.1016\/j.cgh.2007.05.008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref6","article-title":"\"Significance of serum gamma glutamyl transpeptidase in cholestatic jaundice\"","volume":"51","author":"Chand K","year":"1997","unstructured":"Chand K, Thakur S. \"Significance of serum gamma glutamyl transpeptidase in cholestatic jaundice\". Indian J Med Sci. 1997, 51:270-4.","journal-title":"Indian J Med Sci"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1016\/S1665-2681(19)31448-6","article-title":"Prolonged cholestasis triggered by hepatitis A virus infection and variants of the hepatocanalicular phospholipid and bile salt transporters","volume":"11","author":"Krawczyk M","year":"2012","unstructured":"Krawczyk M, Gr\u00fcnhage F, Langhirt M, Bohle RM, Lammert F. Prolonged cholestasis triggered by hepatitis A virus infection and variants of the hepatocanalicular phospholipid and bile salt transporters. Ann Hepatol. 2012, 11:710-4.","journal-title":"Ann Hepatol"},{"key":"ref8","article-title":"Cholestatic hepatitis","year":"2019","unstructured":"Cholestatic hepatitis. LiverTox. Clinical and Research Information on Drug-Induced Liver Injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda (MD); 2019."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22177","article-title":"Acute liver failure: summary of a workshop","volume":"47","author":"Lee WM","year":"2008","unstructured":"Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology. 2008, 47:1401-15. 10.1002\/hep.22177","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1073114","article-title":"Etiologies of acute liver failure","volume":"28","author":"Lee WM","year":"2008","unstructured":"Lee WM. Etiologies of acute liver failure. Semin Liver Dis. 2008, 28:142-52. 10.1055\/s-2008-1073114","journal-title":"Semin Liver Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2015.00052","article-title":"Acetaminophen-induced hepatotoxicity: a comprehensive update","volume":"4","author":"Yoon E","year":"2016","unstructured":"Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N. Acetaminophen-induced hepatotoxicity: a comprehensive update. J Clin Transl Hepatol. 2016, 4:131-42. 10.14218\/JCTH.2015.00052","journal-title":"J Clin Transl Hepatol"},{"key":"ref12","article-title":"Drug-induced hepatotoxicity","author":"Francis P","year":"2024","unstructured":"Francis P, Navarro VJ. Drug-induced hepatotoxicity. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v3.i5.118","article-title":"Symptoms and signs of acute alcoholic hepatitis","volume":"3","author":"Basra G","year":"2011","unstructured":"Basra G, Basra S, Parupudi S. Symptoms and signs of acute alcoholic hepatitis. World J Hepatol. 2011, 3:118-20. 10.4254\/wjh.v3.i5.118","journal-title":"World J Hepatol"},{"key":"ref14","article-title":"Alcoholic-associated hepatitis","author":"Shah NJ","year":"2023","unstructured":"Shah NJ, Royer A, John S. Alcoholic-associated hepatitis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2018-0208-RA","article-title":"Epstein-Barr virus hepatitis: a review of clinicopathologic features and differential diagnosis","volume":"142","author":"Schechter S","year":"2018","unstructured":"Schechter S, Lamps L. Epstein-Barr virus hepatitis: a review of clinicopathologic features and differential diagnosis. Arch Pathol Lab Med. 2018, 142:1191-5. 10.5858\/arpa.2018-0208-RA","journal-title":"Arch Pathol Lab Med"},{"key":"ref16","article-title":"Acute hepatitis induced by Epstein-Barr virus infection: a case report","volume":"18","author":"Do\u011fan I","year":"2007","unstructured":"Do\u011fan I, Erg\u00fcn M, Cindoruk M, Unal S. Acute hepatitis induced by Epstein-Barr virus infection: a case report. Turk J Gastroenterol. 2007, 18:119-21.","journal-title":"Turk J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2013\/6158.3365","article-title":"The value of magnetic resonance cholangio-pancreatography (MRCP) in the detection of choledocholithiasis","volume":"7","author":"Mandelia A","year":"2013","unstructured":"Mandelia A, Gupta AK, Verma DK, Sharma S. The value of magnetic resonance cholangio-pancreatography (MRCP) in the detection of choledocholithiasis. J Clin Diagn Res. 2013, 7:1941-5. 10.7860\/JCDR\/2013\/6158.3365","journal-title":"J Clin Diagn Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v7.i2.137","article-title":"Combination of serum gamma-glutamyltransferase and alkaline phosphatase in predicting the diagnosis of asymptomatic choledocholithiasis secondary to cholecystolithiasis","volume":"7","author":"Mei Y","year":"2019","unstructured":"Mei Y, Chen L, Zeng PF, et al.. Combination of serum gamma-glutamyltransferase and alkaline phosphatase in predicting the diagnosis of asymptomatic choledocholithiasis secondary to cholecystolithiasis. World J Clin Cases. 2019, 7:137-44. 10.12998\/wjcc.v7.i2.137","journal-title":"World J Clin Cases"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2012.03.012","article-title":"Approach to a patient with elevated serum alkaline phosphatase","volume":"16","author":"Siddique A","year":"2012","unstructured":"Siddique A, Kowdley KV. Approach to a patient with elevated serum alkaline phosphatase. Clin Liver Dis. 2012, 16:199-229. 10.1016\/j.cld.2012.03.012","journal-title":"Clin Liver Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13110","article-title":"Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value","volume":"36","author":"de Vries EM","year":"2016","unstructured":"de Vries EM, Wang J, Leeflang MM, et al.. Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value. Liver Int. 2016, 36:1867-75. 10.1111\/liv.13110","journal-title":"Liver Int"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2017.01.42","article-title":"Anti-mitochondrial autoantibodies-milestone or byway to primary biliary cholangitis?","volume":"5","author":"Tanaka A","year":"2017","unstructured":"Tanaka A. Anti-mitochondrial autoantibodies-milestone or byway to primary biliary cholangitis?. Ann Transl Med. 2017, 5:50. 10.21037\/atm.2017.01.42","journal-title":"Ann Transl Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2017.14","article-title":"Diagnostic autoantibodies for autoimmune liver diseases","volume":"6","author":"Toh BH","year":"2017","unstructured":"Toh BH. Diagnostic autoantibodies for autoimmune liver diseases. Clin Transl Immunology. 2017, 6:e139. 10.1038\/cti.2017.14","journal-title":"Clin Transl Immunology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092267","article-title":"Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen\/liver pancreas in autoimmune hepatitis","volume":"9","author":"Zhang WC","year":"2014","unstructured":"Zhang WC, Zhao FR, Chen J, Chen WX. Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen\/liver pancreas in autoimmune hepatitis. PLoS One. 2014, 9:e92267. 10.1371\/journal.pone.0092267","journal-title":"PLoS One"},{"key":"ref24","article-title":"Biochemistry, antinuclear antibodies (ANA)","author":"Nosal RS","year":"2022","unstructured":"Nosal RS, Superville SS, Amraei R, Varacallo MA. Biochemistry, antinuclear antibodies (ANA). StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2022."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3402\/ljm.v5i0.4857","article-title":"Elevated serum immunoglobulin G levels in patients with chronic liver disease in comparison to patients with autoimmune hepatitis","volume":"5","author":"Fallatah HI","year":"2010","unstructured":"Fallatah HI, Akbar HO. Elevated serum immunoglobulin G levels in patients with chronic liver disease in comparison to patients with autoimmune hepatitis. Libyan J Med. 2010, 5:5. 10.3402\/ljm.v5i0.4857","journal-title":"Libyan J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.07.016","article-title":"Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis","volume":"9","author":"Bj\u00f6rnsson E","year":"2011","unstructured":"Bj\u00f6rnsson E, Talwalkar J, Treeprasertsuk S, Neuhauser M, Lindor K. Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis. Clin Gastroenterol Hepatol. 2011, 9:57-63. 10.1016\/j.cgh.2010.07.016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-56378-1.00053-8","article-title":"Autoantibodies in autoimmune hepatitis","author":"Liberal R","year":"2014","unstructured":"Liberal R, Mieli-Vergani G, Vergani D. Autoantibodies in autoimmune hepatitis. Autoantibodies. Shoenfeld Y, Meroni PL, Gershwin ME (ed): Elsevier, Amsterdam, Netherlands; 2014. 451-62. 10.1016\/B978-0-444-56378-1.00053-8"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.01027.x","article-title":"Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes","volume":"118","author":"Klein R","year":"1999","unstructured":"Klein R, Zanger UM, Berg T, Hopf U, Berg PA. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes. Clin Exp Immunol. 1999, 118:290-7. 10.1046\/j.1365-2249.1999.01027.x","journal-title":"Clin Exp Immunol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840070626","article-title":"Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: a second type of \"autoimmune\" hepatitis","volume":"7","author":"Homberg JC","year":"1987","unstructured":"Homberg JC, Abuaf N, Bernard O, et al.. Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: a second type of \"autoimmune\" hepatitis. Hepatology. 1987, 7:1333-9. 10.1002\/hep.1840070626","journal-title":"Hepatology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/161178-a-case-report-of-a-61-year-old-woman-with-jaundice-and-cholelithiasis-presenting-with-autoimmune-hepatitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T15:18:16Z","timestamp":1742397496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/161178-a-case-report-of-a-61-year-old-woman-with-jaundice-and-cholelithiasis-presenting-with-autoimmune-hepatitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.80829","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,19]]}}}